Literature DB >> 3458363

Leukapheresis for control of chronic myelogenous leukemia during pregnancy.

D Fitzgerald, J M Rowe, J Heal.   

Abstract

Leukapheresis was used as the sole modality of treatment of a patient with chronic myelogenous leukemia (CML) during her pregnancy. The specific requirements for safe leukapheresis during pregnancy are discussed, and the literature describing the management of CML during pregnancy is reviewed. Leukapheresis may be the treatment of choice in selected pregnancy patients with CML since it avoids the potential teratogenic effects of chemotherapy or radiation therapy.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3458363     DOI： 10.1002/ajh.2830220213

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  3 in total

Review 1.  Pregnancies in patients with chronic myeloid leukemia in the era of imatinib.

Authors:  Liang-Piu Koh; Devendra Kanagalingam
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

Review 2.  Management of chronic myeloid leukemia in the setting of pregnancy: when is leukocytapheresis appropriate? A case report and review of the literature.

Authors:  Elizabeth M Staley; Sierra C Simmons; Alexander Z Feldman; Robin G Lorenz; Marisa B Marques; Lance A Williams; X Long Zheng; Huy P Pham
Journal:  Transfusion       Date:  2017-12-11       Impact factor: 3.157

3.  A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13).

Authors:  Surachit Kumar; Mariya Apostolova; Paul V Woolley
Journal:  Hematol Rep       Date:  2011-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.